Ensign Peak Advisors
VERA icon

Ensign Peak Advisors’s Vera Therapeutics VERA Stock Holding History

Ensign Peak Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.4M Sell
102,598
-16,077
-14% -$599K 0.01% 589
2026
Q1 		$4.77M Buy
118,675
+116,075
+4,464% +$5M 0.01% 543
2025
Q4 		$132K Sell
2,600
-6,700
-72% -$238K ﹤0.01% 1484
2025
Q3 		$270K Sell
9,300
-4,250
-31% -$98.3K ﹤0.01% 1595
2025
Q2 		$319K Hold
13,550
– – ﹤0.01% 1646
2025
Q1 		$325K Hold
13,550
– – ﹤0.01% 1634
2024
Q4 		$573K Buy
13,550
+1,800
+15% +$79.7K ﹤0.01% 1558
2024
Q3 		$519K Hold
11,750
– – ﹤0.01% 1598
2024
Q2 		$425K Buy
11,750
+1,400
+14% +$55.5K ﹤0.01% 1640
2024
Q1 		$446K Buy
+10,350
New +$369K ﹤0.01% 1648
2023
Q4 		– Sell
-17,816
Closed -$244K – 1762
2023
Q3 		$244K Hold
17,816
– – ﹤0.01% 1717
2023
Q2 		$286K Hold
17,816
– – ﹤0.01% 1717
2023
Q1 		$138K Hold
17,816
– – ﹤0.01% 1750
2022
Q4 		$345K Sell
17,816
-3,300
-16% -$59.8K ﹤0.01% 1695
2022
Q3 		$450K Buy
21,116
+7,839
+59% +$147K ﹤0.01% 1514
2022
Q2 		$181K Hold
13,277
– – ﹤0.01% 1827
2022
Q1 		$312K Buy
+13,277
New +$286K ﹤0.01% 1737

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ensign Peak Advisors's VERA Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Vera Therapeutics (VERA) stake by 14% in Q2 2026, selling an estimated $599K and leaving 102,598 shares worth $4.4M. The position accounts for 0.01% of the portfolio, ranked #589.

Ensign Peak Advisors first reported a position in VERA in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.77M in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Ensign Peak Advisors held 102,598 shares of Vera Therapeutics worth $4.4M as of Q2 2026.
  • Ensign Peak Advisors sold 16,077 Vera Therapeutics shares in Q2 2026, an estimated $599K.
  • Vera Therapeutics made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #589 holding.
  • Ensign Peak Advisors first reported a position in Vera Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Ensign Peak Advisors's Vera Therapeutics position peaked at $4.77M in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.